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Abstract
Background: Shigella is the etiological agent of shigellosis, a disease responsible for more than
500,000 deaths of children per year, in developing countries. These pathogens colonize the
intestinal colon, invade, spreading to the other enterocytes. Breastfeeding plays a very important
role in protecting infants from intestinal infections. Amongst milk compounds, glycosylated
proteins prevent the adhesion of many enteropathogens in vitro. The aim of this work was to
determine the effect of human milk proteins on the colonization potential of Shigella dysenteriae, S.
flexneri and S. sonnei. To fulfill this purpose, pooled milk samples from five donors, were fractionated
by gel filtration and affinity chromatography. Using tissue culture, the milk fractions obtained were
tested in Shigella adhesion and invasion assays.
Results: Our revealed showed that both adhesion and invasion of Shigella species were inhibited
by low concentration of secretory immunoglobulin A, lactoferrin and free secretory component.
This work also showed that, these proteins bind to superficial and whole-cell Shigella proteins.
Conclusions: Our findings suggest that human milk may act inhibiting adhesion and, consequently,
invasion of Shigella, thereafter preventing shigellosis in infants.
Background
Shigella species are common etiological agents of shigello-
sis. This illness is responsible for 500,000 deaths of chil-
dren per year, in developing countries [1]. Clinical
symptoms of shigellosis mainly due to acute inflamma-
tory responses, are characterized by the presence of blood
and mucus in the stools and intense damage of colonic
epithelium. Of the four species of Shigella, three are fre-
quently isolated from dysentery cases: S. dysenteriae, S.
flexneri and S. sonnei [2].
For many enteropathogens, adhesion to the host cells,
mediated by either fimbrial or afimbrial adhesins, has
been shown to be the primordial step of intestinal coloni-
zation [3]. However, in Shigella, adhesion structures have
not been well characterized and the importance of the
adhesion process for colonization and pathogenesis
remains unclear [4]. Conversely, the ability to invade epi-
thelial cells has been largely studied in S. flexneri. A 230
kDa plasmid that encodes many invasion proteins (inva-
sion plasmid antigens – Ipas) and proteins of the type III
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secretion system (Mxi-Spa), was shown to be essential for
the invasion process, allowing the entrance in human
colonic cells, intracellular multiplication and spreading to
adjacent cells [5].
Many epidemiological studies have shown that breast-
feeding protects infants against intestinal infections [6-9].
Immunoglobulins, mainly the secretory immunoglobulin
A (sIgA) [10,11], glycocompounds [10,12] and oligosac-
charides [13] have been implicated in the protection con-
ferred by human milk against different enteropathogens.
The most abundant immunoglobulin of human milk is
sIgA (420 kDa), a dimeric IgA molecule covalently linked
by a J chain and bounded to a molecule of secretory com-
ponent (SC) [13-16]. De Araújo et al., 2000, demon-
strated that sIgA has a protective effect against diffusely
adherent E. coli (DAEC), enteroaggregative E. coli (EAEC)
[17] and enteropathogenic E. coli (EPEC) [18]. Further-
more, Carbonare et al., 1995, reported that sIgA inhibits
the invasion of enteroinvasive Escherichia coli (EIEC) to
HeLa cells [19], an E. coli pathotype that displays a viru-
lence mechanism very similar to Shigella species.
Additionally, non-immunoglobulinic glycocompounds
such as lactoferrin (Lf), an iron-binding glycoprotein and
free secretory component (fSC) have been associated with
milk protection [3,18,20]. It was described that Lf binds to
different radiolabeled proteins from both E. coli and S.
flexneri [21,22]. Likewise, Lf inhibits EPEC adhesion to
HeLa cells [18] and binds to fimbrial structures of entero-
toxigenic E. coli (ETEC) [23]. Recently, Gomez et al., 2002
and 2003, respectively, showed that a high concentration
of recombinant lactoferrin (>1 mg.mL-1), produced in
Saccharomyces cerevisae, protect rabbits against inflamma-
tory enteritis caused by Shigella flexneri [24], and impairs
S. flexneri M90T invasion, but not adhesion to HeLa cells,
by inducing IpaB degradation [25]. Similarly, recent stud-
ies showed that fSC inhibits most the enteroadherent E.
coli, and binds to fimbrial adhesins of ETEC [18,23].
Apart from the Lf data described above, the knowledge
regarding the effects of human milk components on the
adhesion and invasion mechanisms of Shigella towards
host cells is quite reduced. Therefore, the aim of this work
was to investigate the effect of the human milk proteins
on the ability of Shigella to adhere and to invade HeLa
cells. We have also investigated the target bacterial com-
ponents recognized by milk proteins.
Results
Effects of milk protein on Shigella dysenteriae, S. 
flexneri and S. sonnei adhesion and invasion to HeLa cells
The highest protein concentration of whey and casein
used on the assays was 600 µg.mL-1 since the cytotoxic
effects on Hela cells were observed with higher concentra-
tions. While casein did not affect the invasion of the three
Shigella  species tested, whey decreased the number of
invading bacteria in more than 50% (Table 1). E. coli
HB101 and S. flexneri BS176 did not invade HeLa cells
(data not shown).
Fractions corresponding to each peak obtained from the
gel filtration chromatography, at approximately 300
µg.mL-1, were used to determine the capacity of inhibiting
Shigella invasion (Table 1). While P1S (sIgA) and P2S (Lf,
fSC and albumin) exhibited more than 40% inhibition of
Shigella  invasion, P3S (α-lactoalbumin) presented no
effect on Shigella invasion. Since P2S is composed of three
different proteins (Lf, fSC and albumin), this fraction was
further investigated by testing each component individu-
ally. No inhibition of invasion was observed when pure
commercial albumin was used (data not shown). Lf or SC
or both might be responsible for the inhibition when P2S
fraction was assayed.
Table 1: Effect on invasion of S. dysenteriae. S. flexneri and S. sonnei of whey, casein, PIS (sIgA), P2S (Lf, SC and albumin, SA), P3S (α-
lactoalbumin), P2H (fSC and SA) and P3H (Lf).
S. dysenteriae wild type S. flexneri wild type S. sonnei wild type
Bacteria n°/Hela cell % inhibition p bacteria n°/Hela cell % inhibition p bacteria n°/Hela cell % inhibition p
Fraction control Tested control tested control tested
Whey 5.2 ± 0,4 2.2 ± 0,2 58 0.001 0.68 ± 0.2 0.28 ± 0.2 74 0.007 0.49 ± 0.24 0.18 ± 0.15 62 0.008
casein 6.6 ± 1,0 6.5 ± 1,1 - ns 0.89 ± 0.1 0.83 ± 0.2 - ns 0.53 ± 0.10 0.52 ± 0.12 - ns
slgA 6.1 ± 0,1 2.7 ± 0,2 44 0.006 1. 60 ± 0.08 0.56 ± 0.08 58 0.009 1.98 ± 0.60 1.15 ± 0.09 42 0.005
Lf+SC+AS 6.6 ± 0,4 2.7 ± 0,2 59 0.008 0.79 ± 0.04 0.51 ± 0.04 36 0.008 0.70 ± 0.05 0.16 ± 0.05 77 0.007
α-lactoalbumin 7.2 ± 0,4 7.1 ± 0,2 - ns 0.81 ± 0.05 0.79 ± 0.02 - ns 0.92 ± 0.60 0.85 ± 0.45 - ns
fSC 5.8 ± O,5 3.4 ± 0,2 42 0.009 1,3 ± 0.02 0.75 ± 0.04 42 0.003 2.00 ± 0.05 0.84 ± 0.04 58 0.01
Lf 6.2 ± 0,8 3.2 ± 0,1 48 0.002 0.8 ± 0.09 0.42 ± 0.05 48 0.004 1.80 ± 0.02 0.65 ± 0.10 64 0.03
ns = not significative. p = statistical analyses (t-Student independent)BMC Microbiology 2004, 4 http://www.biomedcentral.com/1471-2180/4/18
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Thus, to isolate Lf from the fSC, concentrated whey was
submitted to affinity chromatography on fast-flow
heparin sepharose. Three protein peaks were obtained,
and denominated P1H, P2H and P3H. Electrophoretic
analysis of proteins eluted in each peak revealed that P1H
presented protein bands correspondent to sIgA and α-lac-
toalbumin. P2H presented bands corresponding to fSC
(78 kDa) and albumin (56 kDa). Purified lactoferrin was
eluted in the P3H (78 kDa) (Fig 1). Western blotting anal-
yses of proteins isolated in P2H and P3H using antiserum
to Lf or SC confirmed the presence of fSC in the P2H and
Lf in P3H (Fig. 1). fSC and Lf (~330 µg.mL-1) strongly
inhibited the invasion of the three Shigella species studied
to the HeLa cells (Table 1).
Lf has been associated to a decrease of bacterial growth
[26]. Therefore, the effect of this compound besides fSC
on the growth of three Shigella species was determined,
under the same conditions used in our standard
inhibition assays. No differences on colony forming units
(CFU) in the presence or absence of Lf or fSC were found,
suggesting that, under the assay conditions, purified Lf
and fSC was not able to influence bacterial growth.
The reduced number of bacteria observed inside HeLa
cells when the invasion assay was performed could be due
to either the direct effect of milk proteins on one or more
stages of the invasion process, or to the action of these
compounds impairing bacterial adhesion to the cultured
cells. Whey (2.8 mg.mL-1), sIgA (0.33 mg.mL-1), Lf (0.3
mg.mL-1) and fSC (0.33 mg.mL-1) on Shigella adhesion
was also assayed using the non invasive, but adherent, S.
flexneri BS176 strain and the wild type S. dysenteriae and S.
sonnei strains. The treatment of the Shigella strains with
these compounds leads to a strong inhibition of adhesion
(Table 2).
Effect of antibodies and sodium metaperiodate on the milk 
compounds inhibition activity
The effect of anti-fSC (that also binds to SC complexed
with sIgA) and anti-Lf on the inhibition mediated by fSC,
sIgA and Lf, respectively, were also investigated. The expo-
sition of Lf, fSC and sIgA to their respective antibodies
suppressed the inhibitory effect of these proteins, in both
adhesion and invasion of the three Shigella species. Figure
2 shows the results obtained using S. flexneri. Similar
results were obtained when S. dysenteriae and S. sonnei
were analyzed.
Lf and fSC are highly glycosylated proteins. Therefore, the
outcome of the exposition of these glycoproteins
exposition to sodium metaperiodate was determined. Fig-
ure 2 shows that the treatment reduced the inhibition
ability of Lf and fSC in both, adhesion and invasion of the
three Shigella species to HeLa cells.
Identification of Lf and fSC separated by affinity chromatogra- phy (Heparin Sepharose) Figure 1
Identification of Lf and fSC separated by affinity chromatogra-
phy (Heparin Sepharose). Commassie-blue-stained SDS-
PAGE 12.5%, lanes 1; 3; 5 show the protein content of 
respectively P1H (sIgA and α-lactoalbumin), P2H (fSC and 
albumin) and P3H (Lf). Lanes 2; 4 and 6 represent western 
blotting analysis of P1H, P2H and P3H revealing respectively 
bound SC of sIgA, fSC and isolated lactoferrin.
Table 2: Effect on the adhesion of wild type S. dysenteriae, S. flexneri BS176 and wild type S. sonnei of. whey. PIS (sIgA). P2H (fSC) and 
P3H (Lf).
S. dysenteriae wild type S. flexneri BS176 S. sonnei wild type
Bacteria n°/Hela cell % inhibition p Bacteria n°/Hela cell %inhibition p Bacteria n°/Hela cell % inhibition p
Fraction Control tested control tested control tested
Whey 28.5 ± 3.0 12.5 ± 1.5 66 0.001 19 ± 8.0 5.7 ± 0.4 59 0.03 7.2 ± 1.6 2.64 ± 0.32 63 0.002
sIgA 22.5 ± 0.2 15.0 ± 0.4 33 0.012 8.0 ± 3.0 3.5 ± 1.0 56 0.02 8.8 ± 1.6 5.28 ± 0.8 40 0.025
fSC 24.0 ± 3.0 10.5 ± 4.5 56 0.009 13.0 ± 0.4 3.8 ± 0.8 71 0.01 8.8 ± 0.24 3.52 ± 0.8 60 0.001
Lf 29.5 ± 4.0 13.0 ± 0.5 56 0.009 7.0 ± 0.6 2.0 ± 0.2 71 0.007 7.2 ± 0.96 3.52 ± 1.6 51 0.008
p = statistical analyses (t-Student independent)BMC Microbiology 2004, 4 http://www.biomedcentral.com/1471-2180/4/18
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Binding of sIgA and Lf to bacterial proteins
Secreted and surface proteins (SSP) and intracellular pro-
teins (IP) extracts were used to perform a modified west-
ern blotting to investigate the Lf and sIgA binding abilities
to bacterial components. E. coli HB 101 extracts were used
as negative control. sIgA was able to bind to four (26; 38;
45 and 68 kDa) and seven (23; 35; 38; 49; 56; 57 and 58
kDa) proteins, respectively, from SSP and IP extracts (Fig.
3, lanes 2 and 5). Three proteins (23; 26; and 38 kDa)
from SSP extract and two (23 and 38 kDa) from IP extract
were recognized by Lf (Fig. 3, lanes 3 and 6). No protein
extract from E. coli HB101 was able to bind to sIgA or Lf
(data not shown).
Discussion
In this study, we show that human milk immunoglobulin
fraction (sIgA), fSC and Lf inhibit adhesion and invasion
to HeLa cells by three Shigella species. The inhibitory activ-
ity seems to be similar among the three Shigella species
studied. Thus, the human milk inhibitory activity could
have the same target mechanism, impairing the virulence
of the three species studied.
Several reports have pointed out an important role for
immunoglobulins, mainly sIgA, on human milk protec-
tive effect against diarrhea [14,17,18]. sIgA inhibits the
adherence of many pathotypes of E. coli, including EIEC
Effect of specifics antibodies and sodium metaperiodate (SM)  on the inhibitory activity of sIgA, fSC and Lf on the wild type  S, flexneri invasion (A) and S. flexneri BS176 adhesion (B) Figure 2
Effect of specifics antibodies and sodium metaperiodate (SM) 
on the inhibitory activity of sIgA, fSC and Lf on the wild type 
S, flexneri invasion (A) and S. flexneri BS176 adhesion (B). Inva-
sion and adhesion of S. flexneri on HeLa incubated, white 
bars, or not incubated, black bars, to milk proteins. The 
inhibitory activity of the sIgA, fSC and Lf was lost when incu-
bated with anti-SC or anti-Lf (dots bars) or metaperiodate 
(vertical lines bars). Data presented are means ± standard 
deviations of three separate experiments in triplicate.
Bacterial proteins recognized by sIgA and Lf Figure 3
Bacterial proteins recognized by sIgA and Lf. (A) Surface and 
supernatant proteins. Lane 1, stained with coomassie blue. 
Lane 2 (lanes 2 and 5) and Lf (lanes 3 and 6) bound to super-
natant and surface proteins (A) and intracellular proteins (B). 
Modified Western Blot, after the transference the membrane 
containing SSP and IP was incubated with P1S-sIgA or P3H-Lf 
overnight, following incubation with anti-SC or anti-Lf to 
respective sIgA or Lf. Marked supernatant with surface pro-
teins have 26, 38, 45, 68 kDa and intracellular proteins with 
23; 35; 38; 49; 56; 57; 58 kDa bound to sIgA (lanes 2 and 5). 
Surface proteins with 23; 26; 38 kDa and intracellular pro-
teins with 23; 38 kDa bound to lactoferrin (lanes 3 and 6).BMC Microbiology 2004, 4 http://www.biomedcentral.com/1471-2180/4/18
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which shows similar virulence aspects when compared to
Shigella [18,19]. Similarly, two glycoproteins, Lf and fSC,
were shown to be involved in the inhibition of ETEC,
EAEC and EPEC adherence [23,24]. In the present work,
we have shown that these two glycoproteins, in
concentrations lower than those found in human milk,
inhibited the adhesion and, consequently, the invasion of
the three Shigella species. Furthermore, our findings indi-
cate that sIgA and Lf bind to Shigella superficial proteins
with molecular mass similar to the virulence proteins
involved in the invasion mechanism [27], suggesting that
these components could inhibit the two virulence proc-
esses independently.
Little is know about the role the fSC found in secretions,
although some studies suggest that it may play a protec-
tive role against diarrhea [18,20]. In our work show that
fSC from human milk inhibited the adhesion and inva-
sion of Shigella in vitro, indicating that this compound
may be an important non-specific defense factor. Interest-
ingly, fSC is also found in intestinal secretions where it
may provide protection to mucous membranes, the initial
target in most infections. Our findings further
corroborated this hypothesis since anti-SC diminishes the
inhibition activity of sIgA and fSC on Shigella invasion
and adhesion. Furthermore, it is interesting to note that
anti-SC inhibits the effect of both sIgA and fSC, therefore
the bounded SC of sIgA may be involved on the inhibitory
activity. On the other hand, sIgA complexed with the anti-
SC may lead to esteric impairment.
Lf is considered as an important non-specific defense fac-
tor against gastrointestinal infections, causing microor-
ganisms iron-deprivation by its iron-scavenging ability
[3,26]. In the present work, we show that Lf isolated from
the human milk also affected adhesion and invasion of S.
flexneri  BS176 (S. flexneri M90T cured of the virulence
plasmid), S. flexneri, S. dysenteriae and S. sonnei wild type
strains.
Previous studies [10] have established the association of
fucosylated oligosaccharides in human milk with
adhesion inhibition of enteropathogens to Hep-2 cells. Lf,
sIgA and fSC, rich in fucosylated residues, when treated
with sodium metaperiodate, lose the ability to inhibit
both, Shigella adhesion and invasion. This result confirms
the importance of the sugar residues in natural glycopro-
teins. Gomez et al. showed that recombinant Lf have no
effect on the adhesion of the S. flexneri M90T strain to
HeLa cells [25], probably, due to the recombinant lactof-
errin not to possess the same structure of sugar residues,
loosing the capacity of inhibiting the Shigella adhesion.
Studies have suggested a role of human milk glycocom-
pounds as cell surface homologues, inhibiting pathogen
binding to host cell receptors [28]. Newburg et al., 1992,
described that glycolipid Gb3 from human milk, a natural
shiga toxin receptor, could null the effect of this toxin on
the host cells [12]. Human proteins, such as Lf and fSC
could play the same role, probably acting as receptor ana-
logues of adhesins or invasines. On the other hand, the
work of Gomez et al. [25] indicates that recombinant
lactoferrin promotes a degradation of virulence factors,
such as Ipa B, impairing the formation of the IpaBC com-
plex on the surface of the host cell. Moreover, our findings
suggest that sIgA and Lf bind to proteins with similar mass
of Shigella virulent proteins: IpaJ and MxiJ (26 kDa), VirB
(35 kDa), IpaD (37 kDa), VirA (45 kDa) or IpaA (68 kDa).
These results suggest that Lf and sIgA prevent the interac-
tion between the bacteria and host cells, impairing the
invasion complex formation.
Conclusions
Studies have demonstrated that exclusive breastfeeding
during the first six months of life protects infants against
many bacterial infections. However, the protection mech-
anism against diarrhea remains partially unclear. Our
findings suggest that other human milk components,
different from immunoglobulins, such as fSC and Lf glyc-
oproteins could play an important role protecting against
the adhesion and invasion of Shigella, therefore, prevent-
ing shigellosis in infants.
Methods
Bacterial strains and growth conditions
Strains of S. dysenteriae, S. flexneri and S. sonnei, isolated
from children with diarrhea in Brasília-DF, were provided
by the Health Secretary of Distrito Federal, Brasília-DF-
Brazil. S. flexneri BS176, a 230 kb virulence plasmid cured
strain, was kindly provided by Dr. Philippe Sansonetti –
Institut Pasteur, Paris, France and was used as adherent
and non-invasive control. E. coli HB101 was used as a non
invasive and non adherent control. Bacteria were grown in
Trypticase Soy Broth, (TSB) (Difco, USA) at 37°C,
overnight in a shaker. All strains were stored at -70°C in
TSB medium containing 15% glycerol.
Human milk proteins fractionation
Human milk samples from Brasilia University milk bank
(Brasilia-Brazil), were pooled from five donors in the first
lactation month, to avoid individual variations. Whey was
obtained, as previously described by Mestecky et al. [16].
Briefly, the pooled milk samples were centrifuged for 1 h
at 5000 × g, in order to separate fat and cells. Defatted
milk was acidified to pH 4.6, with citric acid, incubated
overnight, and centrifuged for 20 min at 3000 × g  in
orderto isolate casein. Whey proteins were then concen-
trated by precipitating with 70%; ammonium sulfate
redissolved in Tris HCl pH 7.6 and dialyzed against the
same buffer. Immunoglobulin and non-immunoglobulinBMC Microbiology 2004, 4 http://www.biomedcentral.com/1471-2180/4/18
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fractions of the concentrated whey proteins were sepa-
rated by gel filtration chromatography in a Sephacryl S-
200 HR column (2,6 cm × 80 cm; Amershan Pharmacia
Biotech; Sweden) equilibrated with 0.1 M Tris HCl, pH
7.6; supplemented with 0.2 M NaCl, containing 1 mM
phenylmethanesulfonyl fluoride (PMSF), 0.1% NaN3 and
50 mM of the ε-amino η-caproic acid (ACA). Proteins
were eluted from the column using a Pharmacia Gradi-
frac chromatography system at a flow rate of 3 mL.min-1,
and 1.2 mL fractions were collected. Three protein peaks
(P1S, P2S and P3S) were obtained and analyzed on the
SDS-PAGE as described by De Araújo et al. [17] showing a
typical milk protein profile. For the isolation of Lf and
fSC, concentrated whey was applied on affinity Heparin
Sepharose fast flow column (0.5 cm × 15 cm, Amershan
Biosciences-USA), equilibrated with 0.1 M Tris HCl, pH
8.0 and supplemented as described above. Protein frac-
tions of 1.2 mL were obtained using a flow rate of 0,8
mL.min-1. Proteins were eluted using 0.2–1.0 M NaCl
gradient.
After many chromatographic runs, the fractions obtained
were pooled and the proteins were precipitated with
ammonium sulfate to 70% final saturation, centrifuged,
and dialyzed. The concentrate proteins were resolved on a
12.5% SDS-PAGE performed at a constant voltage of 5
V.cm-1, in a Mini-Protean II cell unit (Bio-Rad, USA).
Protein concentrations were determined according to the
Bradford method [28].
Effect of the milk proteins on bacterial adhesion and 
invasion
Milk proteins effect on invasion of Shigella was assayed as
described by Clerc and co-workers with adaptations [29].
Bacterial cells from mid-log-phase culture were initially
incubated for 30 min with 0,1 M Tris HCl, pH 7.6 (posi-
tive control), casein, whey or whey fractions, resuspended
in 199 medium (Gibco-BRL, Life Technologies, USA),
until the culture reached 0.8 OD (105 CFU.mL-1) at A600,
inoculated in semi-confluent HeLa cells in a 24-well
microtiter plate. The plate was centrifuged for 10 min at
2,200 × g, in order to promote bacterial contact to HeLa
cells, and then incubated for 45 min, at 37°C, in 5% CO2
atmosphere. HeLa cells were washed four times with
phosphate buffered saline (PBS), overlaid with 199
medium containing gentamicin (50 µg.mL-1; Gibco-BRL,
Life Technologies, USA), in order to eliminate extracellu-
lar bacteria, and further incubated for 90 min. HeLa cells
were washed four times with PBS, detached (EDTA 0.5%
and trypsin solution 0.1%), quantified on a Newbauer
chamber, lysed with sodium desoxycholate 0.5%, at room
temperature, with the remaining bacterial suspension
plated on TSA (Difco, USA). CFU were determined after
overnight incubation at 37°C. Similar procedure was per-
formed to measure the effect of milk proteins on bacterial
adhesion, described by Kusters et al. [30]. Clinical isolates
of Shigella and S. flexneri BS176 were grown in a shaking
incubator at 37°C for 18 h. The culture was centrifuged
for 10 min at 3,000 × g. In order to prevent invasion of
wild types bacteria, the pellet was resuspended on TSB
medium contained cloranphenicol (10 µgmL-1, Sigma,
USA) and incubated at 37°C for 30 min. Subsequently,
bacteria were incubated with the milk proteins for 30 min
and added to semi confluent HeLa cell culture. HeLa cells
and CFU were determinate as described above. All experi-
ments were carried out in triplicate in three independent
experiments.
Identification of fSC and Lf components
Protein fractions were resolved in 8% SDS-PAGE, trans-
ferred into nitrocellulose membranes (hybond C, Amer-
shan Biosciences, USA) and immunoblotted. The
membranes were saturated with 0.1% tween 20 (v/v); 1%
bovine seric albumin (w/v), for 12 h at 10°C and incu-
bated with either polyclonal anti-human fSC (Sigma,
USA) or polyclonal anti-human Lf (Sigma, USA) antisera
diluted to 1:2,000. Anti-goat or anti-rabbit peroxidase
conjugated IgG antibodies were diluted to 1:10,000 and
used as secondary antibodies. Proteins bound to these
antibodies were detected by ECL western blotting analysis
system (Amershan Biosciences-USA).
Effects of antibodies on Lf and fSC inhibition
The effect of polyclonal anti-lactoferrin (1:1000; Sigma)
and anti-SC (1:2000; Sigma) was determined by adding
the respective antibody to milk fractions for 1 h, prior
incubation with bacteria cells. The adhesion and invasion
inhibition assays were carried out as described above.
Effect of the sodium metaperiodate on Lf and fSC 
mediated inhibition
Either Lf or fSC (~300 µg.mL-1) were treated with sodium
metaperiodate (0.02 M) at 4°C, for 6 h. Modified glyco-
proteins were utilized in the standard adhesion and inva-
sion inhibition assays.
Human milk components binding to Shigella proteins
Enriched fraction containing either SSP or IP were
extracted from Shigella strains cultured on Congo Red TSB
(Difco, USA). Surface and secreted proteins were prepared
by harvesting bacteria at mid-to-late logarithmic phase
grow, which were heated at 60°C for 40 min, and
centrifuged at 4,000 × g for 20 min. Supernatants were
concentrated with 70% ammonium sulfate. Pellet was
sonicated in 10 mM Tris HCl buffer, pH 8.0, containing 5
mM MgCl2, in order to collect the intracellular proteins.
A modification of the western blotting assay was used to
detect bacterial proteins able to bind to milk components.
SSP and IP extracts were resolved on 8% SDS-PAGE andPublish with BioMed Central    and   every 
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transferred to a nitrocellulose membrane (hybond C,
Amershan Biosciences, USA). The membrane was incu-
bated with milk proteins (either sIgA or Lf) during 4 h at
8°C, followed by incubation with either anti-SC or anti-Lf
diluted to 1:2,000; for 4 h at 8°C. The membrane was
incubated with secondary antibodies (Sigma, USA) and
the reaction was detected using ECL detection system
(Amershan Pharmacia Biosciences, UK).
Statistical analysis
The statistical analyses performed included Student-t test.
SPSS software (version 10.0) as used to determine signifi-
cant results.
Abbreviation list
sIgA – secretory immunoglobulin A, fSC – free secretory
component, Lf – human lactoferrin, SPP – secreted and
periplasmatic proteins, IP – intracellular proteins, SA –
albumin
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